Key result
The fifth Korotkoff sound (phase V) is recommended for measuring diastolic blood pressure in pregnancy, demonstrating 86% inter-observer agreement compared to only 16% for phase IV.
Why the study?
Does using the fifth Korotkoff sound improve the measurement of diastolic blood pressure in pregnant women compared to the fourth Korotkoff sound?
Does using the fifth Korotkoff sound improve the measurement of diastolic blood pressure in pregnant women compared to the fourth Korotkoff sound?
Answers are grounded in this paper and cite their sources.
This editorial supports using the fifth Korotkoff sound (disappearance of sound) rather than the fourth (muffling) for measuring diastolic blood pressure in pregnant women.
The measurement of diastolic blood pressure during pregnancy offers plenty of scope for error. Most people still use a mercury sphygmomanometer, with all the pitfalls that are familiar outside obstetrics–“white coat” hypertension, digit preference, cuff size, differences between arms, and poorly calibrated equipment. To these should be added the influence of posture and gestation in a pregnant woman, so any advance in getting it right is to be welcomed. There is now good evidence to support using the fifth Korotkoff sound when measuring diastolic blood pressure in pregnancy. Although measuring blood pressure and detecting hypertension remain at the core of antenatal monitoring, there has long been uncertainty about whether to record diastolic pressure as the point when the sounds muffle (Korotkoff phase IV) or when they disappear (phase V). The World Health Organisation recommends the use of phase IV,1 …
No takes yet. Share an insight, caveat, or question.
P. C. Rubin (1996) conducted an editorial in Pregnancy. Korotkoff phase V (fifth sound) vs. Korotkoff phase IV (fourth sound) was evaluated on Inter-observer agreement within 5 mm Hg. The fifth Korotkoff sound (phase V) is recommended for measuring diastolic blood pressure in pregnancy, demonstrating 86% inter-observer agreement compared to only 16% for phase IV.
Synapse has enriched 10 related papers. Consider them for comparative context: